Timothy G Healey
CIK 1382032 · SVP, Commercial · last filed 2018-03-07
Timothy G Healey is a SVP, Commercial who has filed 19 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for LNTH, was dated Mar 7, 2018. Across all open-market trades the lifetime net is −$580.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.6M across reported positions. 9 SEC filings were submitted jointly with Lantheus Holdings, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LNTH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
125 CAMBRIDGEPARK DRIVE, 6TH FLOOR
CAMBRIDGE, MA 02140
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | SVP, Commercial | 85,658 | $99.92 | $8.56M | -$456.3K | 8 | 2018-03-07 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | SVP, Commercial Operations | 750 | — | — | -$124.1K | 11 | 2010-02-25 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-07 | LNTH | Grant (A) | +24,772 | $0 | EDGAR |
| 2018-02-27 | LNTH | Mixed | −5,476 | -$107.6K | EDGAR |
| 2017-11-17 | LNTH | Mixed | −16,750 | -$362.2K | EDGAR |
| 2017-03-17 | LNTH | Sell (S) | −11,314 | -$140.6K | EDGAR |
| 2017-02-27 | LNTH | Grant (A) | +32,862 | $0 | EDGAR |
| 2016-11-18 | LNTH | Tax (F) | −5,436 | -$49.2K | EDGAR |
| 2016-01-04 | LNTH | Grant (A) | +67,000 | $0 | EDGAR |
| 2015-12-15 | LNTH | Disp (D) | −67,000 | $0 | EDGAR |
| 2010-02-25 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-02 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Mixed | — | -$28.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.